Cathy Burgess will speak at this event hosted by the India chapter of the Parenteral Drug Association. She will lead a March 13 presentation titled “Understanding the Legal Aspects of Information Provided to Regulators as Part of a Remediation Process | If You Said You Did It–Show It!” and participate in a March 12 panel discussion titled “An Examination of CAPAs Commitments and Remediation Plans.”
This conference discusses topics important to drug manufacturers and FDA including: focusing on medical devices, environmental monitoring, aseptic processing, inspectional trends on cleaning validation/cross contamination issues and findings, compliance, and remediations issues. Hear from Industry subject matter experts on innovative technology, data integrity, internal audits, and aseptic line design in addition to other critical topics that support quality.
For more information, click here.